- India
- /
- Healthcare Services
- /
- NSEI:ENTERO
The Return Trends At Entero Healthcare Solutions (NSE:ENTERO) Look Promising
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Speaking of which, we noticed some great changes in Entero Healthcare Solutions' (NSE:ENTERO) returns on capital, so let's have a look.
Return On Capital Employed (ROCE): What Is It?
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Entero Healthcare Solutions, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.068 = ₹1.2b ÷ (₹27b - ₹8.5b) (Based on the trailing twelve months to December 2024).
Thus, Entero Healthcare Solutions has an ROCE of 6.8%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 14%.
Check out our latest analysis for Entero Healthcare Solutions
In the above chart we have measured Entero Healthcare Solutions' prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Entero Healthcare Solutions .
What The Trend Of ROCE Can Tell Us
While in absolute terms it isn't a high ROCE, it's promising to see that it has been moving in the right direction. The numbers show that in the last four years, the returns generated on capital employed have grown considerably to 6.8%. The amount of capital employed has increased too, by 252%. So we're very much inspired by what we're seeing at Entero Healthcare Solutions thanks to its ability to profitably reinvest capital.
The Bottom Line
To sum it up, Entero Healthcare Solutions has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And with a respectable 40% awarded to those who held the stock over the last year, you could argue that these developments are starting to get the attention they deserve. Therefore, we think it would be worth your time to check if these trends are going to continue.
On the other side of ROCE, we have to consider valuation. That's why we have a FREE intrinsic value estimation for ENTERO on our platform that is definitely worth checking out.
While Entero Healthcare Solutions isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
If you're looking to trade Entero Healthcare Solutions, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Entero Healthcare Solutions might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:ENTERO
Entero Healthcare Solutions
Engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India.
High growth potential with solid track record.
Similar Companies
Market Insights
Community Narratives

